| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 7, 2002
Accepted on November 25, 2002
From the Laboratory for Physiology (G.P.v.N.A., V.W.M.v.H.), Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, and the Gaubius Laboratory TNO-PG (P.K., A.V., V.W.M.v.H.), Leiden, the Netherlands.
* To whom correspondence should be addressed. E-mail: vwm.vanhinsbergh{at}pg.tno.nl.
ObjectiveGrowth factor-induced angiogenesis involves migration of endothelial cells (ECs) into perivascular areas and requires active remodeling of the endothelial F-actin cytoskeleton. The small GTPase RhoA previously has been implicated in vascular endothelial growth factor (VEGF)-induced signaling pathways, but its role has not been clarified.
Methods and ResultsVEGF induced the activation of RhoA and recruited RhoA to the cell membrane of human ECs. This increase in RhoA activity is necessary for the VEGF-induced reorganization of the F-actin cytoskeleton, as demonstrated by adenoviral transfection of dominant-negative RhoA. Rho kinase mediated this effect of RhoA, as was demonstrated by the use of Y-27632, a specific inhibitor of Rho kinase. Inhibition of Rho kinase prevented the VEGF-enhanced EC migration in response to mechanical wounding but had no effect on basal EC migration. Furthermore, in an in vitro model for angiogenesis, inhibition of either RhoA or Rho kinase attenuated the VEGF-mediated ingrowth of ECs in a 3-dimensional fibrin matrix.
ConclusionsVEGF-induced cytoskeletal changes in ECs require RhoA and Rho kinase, and activation of RhoA/Rho kinase signaling is involved in the VEGF-induced in vitro EC migration and angiogenesis.
This article has been cited by other articles:
![]() |
H. N. Woodward, A. Anwar, S. Riddle, L. Taraseviciene-Stewart, M. Fragoso, K. R. Stenmark, and E. V. Gerasimovskaya PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L954 - L964. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. De Smet, I. Segura, K. De Bock, P. J. Hohensinner, and P. Carmeliet Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhattacharya, J. Kwon, X. Li, E. Wang, S. Patra, J. P. Bida, Z. Bajzer, L. Claesson-Welsh, and D. Mukhopadhyay Distinct role of PLC{beta}3 in VEGF-mediated directional migration and vascular sprouting J. Cell Sci., April 1, 2009; 122(7): 1025 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. van Nieuw Amerongen and V. W. M. van Hinsbergh Role of ROCK I/II in vascular branching Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H903 - H905. [Full Text] [PDF] |
||||
![]() |
J. Kroll, D. Epting, K. Kern, C. T. Dietz, Y. Feng, H.-P. Hammes, T. Wieland, and H. G. Augustin Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H893 - H899. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Birukova, I. Cokic, N. Moldobaeva, and K. G. Birukov Paxillin Is Involved in the Differential Regulation of Endothelial Barrier by HGF and VEGF Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mayanagi, T. Morita, K. Hayashi, K. Fukumoto, and K. Sobue Glucocorticoid Receptor-mediated Expression of Caldesmon Regulates Cell Migration via the Reorganization of the Actin Cytoskeleton J. Biol. Chem., November 7, 2008; 283(45): 31183 - 31196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qiao, O. Holian, B.-S. Lee, F. Huang, J. Zhang, and H. Lum Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1161 - C1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Birukova, N. Moldobaeva, J. Xing, and K. G. Birukov Magnitude-dependent effects of cyclic stretch on HGF- and VEGF-induced pulmonary endothelial remodeling and barrier regulation Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L612 - L623. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ispanovic, D. Serio, and T. L. Haas Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation Am J Physiol Cell Physiol, September 1, 2008; 295(3): C600 - C610. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M.L. Beckers, J. J. Garcia-Vallejo, V. W.M. van Hinsbergh, and G. P. van Nieuw Amerongen Nuclear targeting of {beta}-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction Cardiovasc Res, September 1, 2008; 79(4): 679 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ryu, C.-W. Lee, K.-H. Hong, J.-A. Shin, S.-H. Lim, C.-S. Park, J. Shim, K. B. Nam, K.-J. Choi, Y.-H. Kim, et al. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia Cardiovasc Res, May 1, 2008; 78(2): 333 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mahadev, X. Wu, S. Donnelly, R. Ouedraogo, A. D. Eckhart, and B. J. Goldstein Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells Cardiovasc Res, May 1, 2008; 78(2): 376 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Martin, T. Tanos, A. B. Garcia, D. Martin, J. S. Gutkind, O. A. Coso, and M. J. Marinissen The G{alpha}12/13 Family of Heterotrimeric G Proteins and the Small GTPase RhoA Link the Kaposi Sarcoma-associated Herpes Virus G Protein-coupled Receptor to Heme Oxygenase-1 Expression and Tumorigenesis J. Biol. Chem., November 23, 2007; 282(47): 34510 - 34524. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, K.-i. Morishige, T. Takahashi, K. Hashimoto, S. Ogata, S. Tsutsumi, K. Takata, T. Ohta, J. Kawagoe, K. Takahashi, et al. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo Mol. Cancer Ther., May 1, 2007; 6(5): 1517 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Marshall Rho Family GTPase Signaling in Tumor Cell Movement and Angiogenesis Am. Assoc. Cancer Res. Educ. Book, April 14, 2007; 2007(1): 103 - 108. [Full Text] [PDF] |
||||
![]() |
A. M. Guo, A. S. Arbab, J. R. Falck, P. Chen, P. A. Edwards, R. J. Roman, and A. G. Scicli Activation of Vascular Endothelial Growth Factor through Reactive Oxygen Species Mediates 20-Hydroxyeicosatetraenoic Acid-Induced Endothelial Cell Proliferation J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 18 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lamalice, F. Le Boeuf, and J. Huot Endothelial Cell Migration During Angiogenesis Circ. Res., March 30, 2007; 100(6): 782 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Su, M. Hodnett, N. Wu, A. Atakilit, C. Kosinski, M. Godzich, X. Z. Huang, J. K. Kim, J. A. Frank, M. A. Matthay, et al. Integrin {alpha}vbeta5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier Function Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zeng, S. M. Taylor, J. R. McColm, N. C. Kappas, J. B. Kearney, L. H. Williams, M. E. Hartnett, and V. L. Bautch Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation Blood, February 15, 2007; 109(4): 1345 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yao, R.-H. Zhou, M. Petreaca, L. Zheng, J. Shyy, and M. Martins-Green Activation of sterol regulatory element-binding proteins (SREBPs) is critical in IL-8-induced angiogenesis J. Leukoc. Biol., September 1, 2006; 80(3): 608 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N.A. Bijman, G. P. van Nieuw Amerongen, N. Laurens, V. W.M. van Hinsbergh, and E. Boven Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton. Mol. Cancer Ther., September 1, 2006; 5(9): 2348 - 2357. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Lee, R. T.P. Poon, A. P. Yuen, K. Man, Z. F. Yang, X. Y. Guan, and S. T. Fan Rac Activation Is Associated with Hepatocellular Carcinoma Metastasis by Up-regulation of Vascular Endothelial Growth Factor Expression Clin. Cancer Res., September 1, 2006; 12(17): 5082 - 5089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. G. Versteilen, I. J. M. Korstjens, R. J. P. Musters, A. B. J. Groeneveld, and P. Sipkema Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney Am J Physiol Renal Physiol, September 1, 2006; 291(3): F606 - F611. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Su, Z. Cui, Z. Li, and E. R. Block Calpain-2 regulation of VEGF-mediated angiogenesis FASEB J, July 1, 2006; 20(9): 1443 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wojciak-Stothard, L. Y. F. Tsang, E. Paleolog, S. M. Hall, and S. G. Haworth Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1173 - L1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, J. Murtagh, and E. L. Schwartz The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere) Mol. Pharmacol., April 1, 2006; 69(4): 1207 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu and A. Horowitz A PDZ-binding Motif as a Critical Determinant of Rho Guanine Exchange Factor Function and Cell Phenotype Mol. Biol. Cell, April 1, 2006; 17(4): 1880 - 1887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Birukova, D. Adyshev, B. Gorshkov, G. M. Bokoch, K. G. Birukov, and A. D. Verin GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L540 - L548. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Eringa, C. D. A. Stehouwer, K. Walburg, A. D. Clark, G. P. van Nieuw Amerongen, N. Westerhof, and P. Sipkema Physiological Concentrations of Insulin Induce Endothelin-Dependent Vasoconstriction of Skeletal Muscle Resistance Arteries in the Presence of Tumor Necrosis Factor-{alpha} Dependence on c-Jun N-Terminal Kinase Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 274 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Breslin, H. Sun, W. Xu, C. Rodarte, A. B. Moy, M. H. Wu, and S. Y. Yuan Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H741 - H750. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hu, S. P. RamachandraRao, S. Siva, C. Valancius, Y. Zhu, K. Mahadev, I. Toh, B. J. Goldstein, M. Woolkalis, and K. Sharma Reactive oxygen species production via NADPH oxidase mediates TGF-{beta}-induced cytoskeletal alterations in endothelial cells Am J Physiol Renal Physiol, October 1, 2005; 289(4): F816 - F825. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Goyal, D. Pandey, A. Behring, and W. Siess Inhibition of Nuclear Import of LIMK2 in Endothelial Cells by Protein Kinase C-dependent Phosphorylation at Ser-283 J. Biol. Chem., July 29, 2005; 280(30): 27569 - 27577. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Hyvelin, K. Howell, A. Nichol, C. M. Costello, R. J. Preston, and P. McLoughlin Inhibition of Rho-Kinase Attenuates Hypoxia-Induced Angiogenesis in the Pulmonary Circulation Circ. Res., July 22, 2005; 97(2): 185 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Swant, B. E. Rendon, M. Symons, and R. A. Mitchell Rho GTPase-dependent Signaling Is Required for Macrophage Migration Inhibitory Factor-mediated Expression of Cyclin D1 J. Biol. Chem., June 17, 2005; 280(24): 23066 - 23072. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Hong, J. Ryu, and K. H. Han Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A Blood, February 15, 2005; 105(4): 1405 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Eringa, C. D. A. Stehouwer, G. P. van Nieuw Amerongen, L. Ouwehand, N. Westerhof, and P. Sipkema Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2043 - H2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Kearney, N. C. Kappas, C. Ellerstrom, F. W. DiPaola, and V. L. Bautch The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis Blood, June 15, 2004; 103(12): 4527 - 4535. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Breslin and S. Y. Yuan Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1057 - H1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Hoang, M. C. Whelan, and D. R. Senger Rho activity critically and selectively regulates endothelial cell organization during angiogenesis PNAS, February 17, 2004; 101(7): 1874 - 1879. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |